Franklin Biotechnology Discovery Fund W(acc)USD

Registreer u om de ratings zichtbaar te maken
Hoe heeft dit fonds gepresteerd?31-12-2021
Ontwikkeling van EUR 1000 (EUR) Uitgebreide Grafiek
Franklin Biotechnology Discovery Fund W(acc)USD
Fonds3,4-11,337,117,9-10,4
+/-Cat-2,6-2,49,8-1,3-7,3
+/-Idx-3,4-7,19,71,9-18,0
 
Kerngegevens
Koers
21-01-2022
 USD 15,87
Rendement 1 Dag -1,11%
Morningstar Categorie™ Aandelen Sector Biotechnologie
Vestigingsland Luxemburg
ISIN LU0976566496
Grootte Fonds (Mil)
31-12-2021
 USD 2145,44
Grootte Fondsklasse (Mil)
31-12-2021
 USD 31,91
Aankoopkosten (Max) -
Lopende Kosten Factor
24-01-2021
  1,03%
Morningstar Research
Analyst Report

Franklin Biotechnology Discovery benefits from an experienced team, but limited resources and an undifferentiated process earn the fund a Morningstar Analyst Rating of Neutral.This strategy was caught flat-footed in 2021, and its poor performance...

Klik hier voor het analistenrapport
Pijlers Morningstar
TeamAverage
FondshuisAverage
ProcesAverage
Rendement
Kosten
Beleggingsdoelstelling: Franklin Biotechnology Discovery Fund W(acc)USD
The Fund invests principally in equity securities of biotechnology companies and discovery research firms located in the US and other countries and to a lesser extent in debt securities of any type of issuers worldwide. For the Fund’s investment purposes, a biotechnology company is one that has at least 50% of its earnings derived from biotechnology activities, or at least 50% of its assets devoted to such activities based on the company’s most recent fiscal year. Biotechnology activities are research, development, manufacture, and distribution of various biotechnological or biomedical products, services and processes. This may include companies involved with genomics, genetic engineering, and gene therapy. It also includes companies involved in the application and development of biotechnology in areas such as health care, pharmaceuticals, and agriculture.
Returns
Rendementen %21-01-2022
YTD-12,42
3 Jaar geannualiseerd3,35
5 Jaar geannualiseerd2,61
10 Jaar geannualiseerd*12,43
Dividendrendement 12M 0,00
Management
Naam manager
Aanvangsdatum
Evan McCulloch
03-04-2000
Wendy Lam
01-09-2018
Click here to see others
Oprichtingsdatum
25-10-2013
Advertentie
Categorie Benchmark
Benchmark van het fondsBenchmark Morningstar
NASDAQ Biotechnology TR USDNASDAQ Biotechnology TR USD
Target Market
Role In Portfolio
Standalone / CoreNiet specifiek
ComponentNiet specifiek
OverigNiet specifiek
Primary Objective
BehoudNiet specifiek
Groeija
InkomenNiet specifiek
HedgingNiet specifiek
OverigNiet specifiek
Waar belegt het fonds in?  Franklin Biotechnology Discovery Fund W(acc)USD31-12-2021
Morningstar Style Box®
Stijl aandelen
Assetverdeling
  % Long% Short% Netto
Positie
Aandelen96,920,0096,92
Obligaties0,230,000,23
Kas/geldmarkt2,700,761,93
Overig0,910,000,91
Top 5 regio's%
Verenigde Staten92,60
Azië - Emerging3,05
Verenigd Koninkrijk2,28
Canada0,94
West Europa – Niet Euro0,66
Top 5 sectoren%
Gezondheidszorg98,93
Financiële Dienstverlening1,07
Top 5 positiesSector%
Regeneron Pharmaceuticals IncGezondheidszorgGezondheidszorg5,98
Vertex Pharmaceuticals IncGezondheidszorgGezondheidszorg5,63
Amgen IncGezondheidszorgGezondheidszorg5,54
Gilead Sciences IncGezondheidszorgGezondheidszorg5,29
Horizon Therapeutics PLCGezondheidszorgGezondheidszorg5,10
Franklin Biotechnology Discovery Fund W(acc)USD

Related

* This share class has performance data calculated prior to the inception date, 2013-10-25. This is based upon a simulated/extended track record, using the track record of Franklin Biotechnology Discv A(acc)USD (ISIN: LU0109394709), and is in accordance with Morningstar’s Extended Performance Methodology paper. To find out more about this, click here.
Om consistentie aan te brengen in de data die diverse vermogensbeheerders aanleveren, worden de gepresenteerde datapunten berekend aan de hand van Morningstar’s eigen berekeningsmethodologie die in detail wordt uitgelegd op(https://www.morningstar.com/research/signature)
© Copyright 2022 Morningstar, Inc. Alle rechten voorbehouden.

Voorwaarden        Privacybeleid        Cookie Settings